Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G ↓	Ingredients	Dosage	Form	Price
J01CA04	OSPAMOX	G	Amoxicillin (trihydrate) - 750mg	750mg	Tablet, film coated	499,372 L.L
M01AB05	OLFEN-50	G	Diclofenac sodium - 50mg	50mg	Tablet, gastroresistant	248,611 L.L
J01CA04	OSPAMOX	G	Amoxicillin (trihydrate) - 250mg/5ml	250mg/5ml	Powder for suspension	223,078 L.L
C10AA05	ORBALIP	G	Atorvastatin (calcium) - 10mg	10mg	Tablet	966,287 L.L
C10AA05	ORVASTA	G	Atorvastatin - 10mg	10mg	Tablet, film coated	834,526 L.L
J01CA04	OSPAMOX	G	Amoxicillin (trihydrate) - 1g	1,000mg	Tablet, film coated	683,273 L.L
M01AB05	OLFEN-100 SR	G	Diclofenac sodium - 100mg	100mg	Capsule, prolonged release	503,941 L.L
M01AB05	OLFEN 75MG	G	Diclofenac sodium - 75mg	75mg	Injectable solution	334,617 L.L
M01AB05	OLFEN-75 SR	G	Diclofenac sodium - 75mg	75mg	Tablet, prolonged release	326,554 L.L
A02BC01	OMEDAR	G	Omeprazole - 20mg	20mg	Tablet, enteric coated	18,087,352 L.L
A02BC01	OMEPRAL	G	Omeprazole - 20mg	20mg	Capsule, delayed release	213,735 L.L
C10AA05	ORBALIP	G	Atorvastatin (calcium) - 20mg	20mg	Tablet	1,091,712 L.L
A02BC01	OMEPRAZOLE PHARMADEX	G	Omeprazole - 20mg	20mg	Capsule	415,951 L.L
C10AA05	ORVASTA	G	Atorvastatin - 20mg	20mg	Tablet, film coated	920,532 L.L
A02BC01	OMEPRAZOLE PHARMADEX	G	Omeprazole - 20mg	20mg	Capsule	15,757,784 L.L
A02BC01	OMEZOL BENTA	G	Omeprazole - 20mg	20mg	Capsule	550,336 L.L
A02BC01	OMEZOL BENTA	G	Omeprazole - 20mg	20mg	Capsule	317,403 L.L
A02BC01	OMEPRAL	G	Omeprazole - 40mg	40mg	Capsule, delayed release	499,142 L.L
R06AD08	OXOMIL	G	Oxomemazine HCl - 0.33mg/ml	0.33mg/ml	Syrup, sugar free	511,940 L.L
R06AD08	OXOMEMAZINE ARROW	G	Oxomemazine HCl - 0.33mg/ml	0.33mg/ml	Syrup	431,373 L.L
R06AD08	OXOMEMAZINE ARROW	G	Oxomemazine HCl - 0.33mg/ml	0.33mg/ml	Solution, sugar free	431,373 L.L
A02BC01	OMEPRAZOLE ARROW	G	Omeprazole - 40mg	40mg	Injectable powder for solution	454,219 L.L
A02BC01	OMEPRAZOLE VIANEX	G	Omeprazole (sodium) - 40mg	40mg	Injectable powder for solution+diluent	467,657 L.L
J01GB06	ORLOBIN	G	Amikacin (sulfate) - 500mg/2ml	500mg/2ml	Injectable solution	329,241 L.L
A02BC01	OMEPRAZOLE-ORBUCELL	G	Omeprazole (sodium) - 40mg	40mg	Injectable solution	3,839,550 L.L
J01MA01	OFLACIN	G	Ofloxacin - 200mg	200mg	Tablet, film-scored	602,041 L.L
J01MA01	OFLOMED	G	Ofloxacin - 200mg	200mg	Tablet, film-scored	601,530 L.L
C10AA05	ORBALIP	G	Atorvastatin (calcium) - 40mg	40mg	Tablet	1,405,275 L.L
A02BC01	OMEPRAL	G	Omeprazole - 20mg	20mg	Powder for suspension	712,876 L.L
C10AA05	ORVASTA	G	Atorvastatin - 40mg	40mg	Tablet, film coated	1,170,487 L.L

...